BDNF and major depressive disorder: In a separate study, Yang and collaborators [21] examined the relationship between the tissue plasminogen activator (tPA)/plasminogen activator inhibitor-1 (PAI-1) system, the BDNF/proBDNF ratio, and SSRI antidepressant treatment over a 4-week period in 57 patients with MDD.